Background: A case of exudative macroaneurysms in unilateral Eales' disease is reported. 'Eales disease' is an idiopathic bilateral occlusive periphlebitis with neovascularisation and mostly presents with vitreous hemorrhage. Case: A 30 year old male presented with diminution of vision in left eye (6/36) for 1 month. Slit Lamp examination of both eyes revealed normal anterior segment. Fundus examination of left eye with + 90 D lens revealed reddish lesions at the macula with surrounding circinate exudation. On peripheral examination hemorrhages were seen along with vasculitis in the superotemporal quadrant.The right eye fundus was normal.All laboratory investigations were found within normal limits. Conclusion: Eales' disease is mostly a bilateral condition but this case is rare as there is uniocular involvement with exudative macroaneurysms.Laser therapy was instituted which was effective in management of this condition with restoration of normal visual acuity.There was no relapse on follow up for 2 years.
Introduction
In 1880, Henry Eales first described this disease in healthy young men with abnormal retinal veins, peripheral neovascularization, and recurrent vitreous hemorrhages.It is an idiopathic obliterative vasculopathy that usually involves the peripheral retina of young adults. It is an important cause of visual morbidity in young Asian males and rare in Caucasians. It is strongly associated with tuberculoprotein hypersensitivity. Presentation is usually in the 3rd-5th decades with vitreous haemorrhage.
The anterior chamber may exhibit cell and flare with keratic precipitates. Vitreous debris and cells often are seen, even in the absence of vitreous hemorrhage. Peripheral nonperfusion is a typical feature of Eales' disease. The surrounding vasculature is tortuous with microvascular abnormalities, which include the following: macroaneurysms, arteriovenous shunts, venous beading, hard exudates, and cotton-wool spots. Macroaneurysms are of three types: hemorrhagic, exudative and quiescent. Hemorrhagic macroaneurysms are associated with dot and blot hemorrhages, exudative macroaneurysms are associated with lipid exudation where as quiescent macroaneurysms are inactive. We report a case of exudative macroaneurysms in unilateral Eales' disease.
Case report
A 30 years old male presented with decreased vision in left eye. On ocular examination the visual acuity (VA) in his right eye was 6/6, while in left eye was 6/36. Patient complained of blurring of vision in his left eye for one week. On silt lamp biomicroscopy examination the anterior segment of both eyes were normal. Intraocular pressure (IOP) was 16 mmHg in right eye and was 18 mmHg in left.Dilated fundus examination with +90 D lens of the left eye revealed reddish lesions at the macula with surrounding circinate exudation. Superotemporally hemorrhages were seen along with vasculitis. The right eye fundus was normal.
Laboratory investigations including blood glucose,complete blood count, angiotensin converting enzyme and lysozyme, antinuclear antibody, rheumatoid factor and ESR were found to be within normal limits.Tuberculin test and chest X-ray were also normal.
Imaging like optical coherence tomography (OCT) was done which showed perifoveal hard exudates and neurosensory detachment at macula (Figure1). FFA of right eye was normal.
Treatment
Modified grid laser photocoagulation was done as oedema and exudates involved the macula and there was documented visual deterioration (Fig 4. ).
Grid laser stimulates the RPE pump mechanism leading to enchanced removal of fluid from subretinal space and resolution of macular edema. Nepafenac eye drops were instilled twice daily for 3 months in the affected eye.The exudates and hemorrhages resolved and visual acuity of the patient improved to 6/6 after 6 months.The patient has been maintaining stable visual acuity since then without any relapse.
Discussion
Laser treatment is safe and effective in the management of macular edema occuring as a result of exudation from macroaneurysms. Indications for laser treatment include visionloss due to chronic macular exudates or edema. (Rabb et al, 1988) Laser photocoagulation directly to the macroaneurysm using xenon arc, argon, or dye yellow has been documented in the literature to improve vision in some patients. (Rabb et al, 1988; Abdel-Khalek and Richardson, 1986; Hudomel and lmre, 1973) However, some studies note that direct photocoagulation to the macroaneurysm does not improve visual outcomes and may lead to branch retinal artery occlusion. (Brown et al, 1994) Indirect laser treatment to the area surrounding the macroaneurysm may also improve visual outcomes in some patients with macular edema. (Robertson, 1973; Palestine et al, 1982; Francois, 1979) Laser hyaloidotomy using a neodymium-doped yttrium aluminium garnet (Nd:YAG) laser for subhyaloid hemorrhage has been reported but is controversial due to the risk of vitreous hemorrhage or damage to the macula. (Tassignon et al, 1989) As macular edema resolved after laser photocoagulation visual acuity of the patient improved and finally patient had 6/6 vision in the affected eye. There was no adverse effect of laser photocoagulation in the affected eye of the patient. There was no relapse and the patient has been maintaining stable vision of 6/6 since then.
Eales' disease is mostly a bilateral conditionand is associated with vascular anomalies like macroaneurysms,arteriovenous shunts, venous beading,vitreous hemorrhage etc. These microvascular anomalies occur due to inflammatory weakening of vessel wall because of recurrent vessel wall inflammation. This case is rare as there is only uniocular involvement with fundus picture suggestive of Eales' disease with associated exudative macroaneurysms.
Laser therapy is effective technique in the management of exudative macroaneurysms and helps in restoration of normal visual acuity as seen in this case. The visual acuity remained stable and there was no relapse.
On thorough search of literature, it has been found that unilateral Eales' disease with exudative macroaneurysms has not been reported till date.
